Global Cancer Microbiome Market Forecast: Trends, Share, and Growth Drivers
The global cancer microbiome market size was USD 222.79 Million in 2022 and is expected to register a steady revenue CAGR of 19.9% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer is a major factor driving market revenue growth. Microbiome is a collection of bacteria that live in and on human body, which have potential to affect initiation, progression, and treatment response of cancer, including cancer immunotherapy. The latest research on the Cancer Microbiome market applies both qualitative and quantitative data analysis to present an overview of the future adjacencies around the Cancer Microbiome industry. An extensive study of the product application and services conducted by subject matter experts assessing the Cancer Microbiome market will help product owners to make a wise decision. From analyzing which products companies should produce, expand to how brands should position their product the study covers...